PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000851376.34315.4f |
| _version_ | 1797287180313296896 |
|---|---|
| author | L. Schaff M. Lobbous D. Carlow L. DeAngelis L. B. Nabors C. Grommes |
| author_facet | L. Schaff M. Lobbous D. Carlow L. DeAngelis L. B. Nabors C. Grommes |
| author_sort | L. Schaff |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:29:13Z |
| format | Article |
| id | doaj.art-a4bcd60574a24ee79b3331c28a5a4e12 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:29:13Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a4bcd60574a24ee79b3331c28a5a4e122024-03-02T06:41:31ZengWileyHemaSphere2572-92412022-06-0162007200810.1097/01.HS9.0000851376.34315.4f202206003-02007PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMICL. Schaff0M. Lobbous1D. Carlow2L. DeAngelis3L. B. Nabors4C. Grommes51 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY2 Neurology, University of Alabama at Birmingham, Birmingham, AL3 Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, United States of America1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY2 Neurology, University of Alabama at Birmingham, Birmingham, AL1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NYhttp://journals.lww.com/10.1097/01.HS9.0000851376.34315.4f |
| spellingShingle | L. Schaff M. Lobbous D. Carlow L. DeAngelis L. B. Nabors C. Grommes PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC HemaSphere |
| title | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
| title_full | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
| title_fullStr | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
| title_full_unstemmed | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
| title_short | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
| title_sort | pb2136 planned use glucarpidase for outpatient high dose methotrexate hd mtx administration in patients with cns lymphoma cnsl during the covid 19 pandemic |
| url | http://journals.lww.com/10.1097/01.HS9.0000851376.34315.4f |
| work_keys_str_mv | AT lschaff pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT mlobbous pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT dcarlow pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT ldeangelis pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT lbnabors pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT cgrommes pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic |